The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
||||||||||||||||
| COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
| VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
| NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
| 10x Genomics, Inc. | CL A COM | 88025u109 | 10,240 | 359,554 | SH | SOLE | 359,554 | 0 | 0 | ||
| Aadi Bioscience, Inc. | COM | 00032Q104 | 7,437 | 526,329 | SH | SOLE | 526,329 | 0 | 0 | ||
| Adicet Bio, Inc. | COM | 007002108 | 8,248 | 580,000 | SH | SOLE | 580,000 | 0 | 0 | ||
| Albireo Pharma, Inc. | COM | 01345P106 | 12,068 | 623,342 | SH | SOLE | 623,342 | 0 | 0 | ||
| Alpine Immune Sciences, Inc. | COM | 02083G100 | 48,300 | 6,708,288 | SH | SOLE | 6,708,288 | 0 | 0 | ||
| Apexigen, Inc. | COM | 03759B102 | 5,115 | 1,894,551 | SH | SOLE | 1,894,551 | 0 | 0 | ||
| Arcus BioSciences, Inc. | COM | 03969f109 | 22,754 | 869,790 | SH | SOLE | 869,790 | 0 | 0 | ||
| Argenx SE | COM | 04016x101 | 1,952 | 5,529 | SH | SOLE | 5,529 | 0 | 0 | ||
| AtriCure Inc. | COM | 004963C20 | 1,809 | 46,259 | SH | SOLE | 46,259 | 0 | 0 | ||
| Aura Biosciences, Inc. | COM | 05153U107 | 3,805 | 210,000 | SH | SOLE | 210,000 | 0 | 0 | ||
| BeyondSpring Inc. | SHS | G10830100 | 4,909 | 4,958,143 | SH | SOLE | 4,958,142 | 0 | 0 | ||
| Cue Health Inc. | COM | 229790100 | 27,033 | 8,980,909 | SH | SOLE | 8,980,909 | 0 | 0 | ||
| Equillium Inc. | COM | 29446K106 | 9,873 | 4,447,308 | SH | SOLE | 4,447,308 | 0 | 0 | ||
| Horizon Therapeutics PLC | COM | G46188101 | 4,883 | 78,900 | SH | SOLE | 78,900 | 0 | 0 | ||
| Illumnia, Inc. | COM | 452327109 | 24,829 | 130,138 | SH | SOLE | 130,138 | 0 | 0 | ||
| Mersana Therapeutics, Inc. | COM | 59045L106 | 6,113 | 904,268 | SH | SOLE | 904,268 | 0 | 0 | ||
| Nautilus Biotechnology, Inc. | COM | 63909J108 | 636 | 300,000 | SH | SOLE | 300,000 | 0 | 0 | ||
| NeuBase Therapeutics, Inc. | COM | 64132K102 | 395 | 1,000,000 | SH | SOLE | 1,000,000 | 0 | 0 | ||
| Owlet, Inc. | COM CL A | 69120X107 | 961 | 898,400 | SH | SOLE | 898,400 | 0 | 0 | ||
| Pacific Biosciences of California, Inc. | COM | 69404D108 | 8,505 | 1,463,872 | SH | SOLE | 1,463,872 | 0 | 0 | ||
| Prometheus Biosciences, Inc. | COM | 74349U108 | 14,753 | 250,000 | SH | SOLE | 250,000 | 0 | 0 | ||
| Scynexis Inc. | COM NEW | 811292200 | 1,333 | 555,555 | SH | SOLE | 555,555 | 0 | 0 | ||
| Seagen Inc. | COM | 812578102 | 3,149 | 23,014 | SH | SOLE | 23,014 | 0 | 0 | ||
| Sema4 Holings Corp. | COM CL A | 81663L101 | 3,002 | 3,418,929 | SH | SOLE | 3,418,929 | 0 | 0 | ||
| Terns Pharmaceuticals, Inc. | COM | 880881107 | 4,207 | 714,285 | SH | SOLE | 714,285 | 0 | 0 | ||
| Zentalis Pharmaceuticals Inc. | COM | 98943L107 | 39,520 | 1,824,583 | SH | SOLE | 1,824,583 | 0 | 0 | ||